Has Akshay Sharma received payments from drug or device companies?

Yes. Drug and device makers reported $92,433 in general payments to Akshay Sharma across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Akshay Sharma did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Akshay Sharma come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Akshay Sharma

Pediatric Hematology-Oncology · Memphis, TNNPI 1558630624

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $87,943 of the $92,433 with a category attached, or 95.1%. 11 manufacturers reported payments, led by Vertex at 29.5% of the total. 2025 is the largest year on record at $35,927, more than ten times the $145 reported in 2019. Among pediatric hematology-oncology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,433in general payments, 2019–2025

Across 61 payments — averaging $1515.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertex$27K
National Marrow Donor Program$26K
Gamida Cell Inc.$14K
E.r. Squibb & Sons, L.L.C.$12K
Pfizer$5K
Biolinerx USA, Inc.$4K
plus $3K from 5 others

$4,424,908in research payments, 2019–2025

Across 31 payments — averaging $142,739 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertex$3.8M
Novartis$631K

What the payments were for

Consulting fees$87,94395%
Speaking & faculty fees$8751%
Travel & lodging$2,4193%
Food & beverage$1,1961%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertex	25	$27,288
National Marrow Donor Program	15	$26,375
Gamida Cell Inc.	4	$14,480
E.r. Squibb & Sons, L.L.C.	6	$12,288
Pfizer	1	$5,000
Biolinerx USA, Inc.	2	$4,125
Medexus Pharma, Inc.	1	$2,040
AstraZeneca	2	$300
Sobi, Inc	2	$232
Chiesi USA, Inc.	2	$160
Novartis	1	$145

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

APHEXDA$12,723
CASGEVY$9,240
OMISIRGE$5,883
ATGAM$5,000
Gamifant$232
ULTOMIRIS$150
SOLIRIS$150

How this compares

$92,433 in reported general payments places this provider in the 95th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee →

Other pediatric hematology-oncology in Memphis

Scott HowardMemphis$1.5M
Ellis NeufeldMemphis$263K
Deepa ManwaniMemphis$143K
Alberto PappoMemphis$88K
Ching-Hon PuiMemphis$75K
Hiroto InabaMemphis$67K
Caitlyn DuffyMemphis$50K
Amar GajjarMemphis$45K
Gary MyersMemphis$44K
Rohith JesudasMemphis$41K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →